Korpanty, G. J., Graham, D. M., Vincent, M. D., & Leighl, N. B. (2014). Biomarkers That Currently Affect Clinical Practice in Lung Cancer: EGFR, ALK, MET, ROS-1, and KRAS. Frontiers Media S.A.
استشهاد بنمط شيكاغوKorpanty, Grzegorz J., Donna M. Graham, Mark D. Vincent, و Natasha B. Leighl. Biomarkers That Currently Affect Clinical Practice in Lung Cancer: EGFR, ALK, MET, ROS-1, and KRAS. Frontiers Media S.A, 2014.
MLA استشهادKorpanty, Grzegorz J., Donna M. Graham, Mark D. Vincent, و Natasha B. Leighl. Biomarkers That Currently Affect Clinical Practice in Lung Cancer: EGFR, ALK, MET, ROS-1, and KRAS. Frontiers Media S.A, 2014.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.